BRIEF

on Telomir Pharmaceuticals, Inc

Telomir Pharmaceuticals' Dr. Michael Roizen to Discuss Longevity on Fox Business

This Sunday, September 29, 2024, Telomir Pharmaceuticals will be highlighted on Fox Business Network's "Health Uncensored with Dr. Drew" at 5:30 PM EST. Dr. Michael Roizen, the company's Special Advisor and Emeritus Chief Wellness Officer at Cleveland Clinic, will delve into the science of longevity and the significance of telomeres in the aging process.

During the segment, Dr. Roizen will discuss Telomir-1, a novel molecule aimed at elongating telomere caps to potentially enhance human and canine lifespans. The conversation will focus on how telomeres affect aging and how Telomir-1 aims to address age-related conditions.

Erez Aminov, Telomir's Chairman and CEO, emphasized the company's ongoing research to expedite regulatory applications for Telomir-1 in both veterinary and human medicine. Aminov noted the company's commitment to accelerating clinical trials for what could be a significant breakthrough in longevity science.

The company encourages audiences to tune in and learn more about the future of therapies targeting the aging process.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Telomir Pharmaceuticals, Inc news